Filing Details
- Accession Number:
- 0001127602-21-016063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-10 13:00:00
- Reporting Period:
- 2021-05-06
- Accepted Time:
- 2021-05-10 16:31:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1231427 | Christopher Patusky | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-05-06 | 2,500 | $63.90 | 4,800 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-05-06 | 2,500 | $192.07 | 2,300 | No | 4 | D | Direct | |
Common Stock | Disposition | 2021-05-10 | 100 | $190.52 | 1,200 | No | 4 | S | Indirect | By Family Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | S | Indirect | By Family Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Share Tracking Award | Disposition | 2021-05-06 | 2,500 | $0.00 | 2,500 | $63.90 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,500 | 2014-06-26 | 2023-06-26 | No | 4 | M | Direct |
Footnotes
- This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.